Sharyl Attkisson is compiling a running list of all covid vaccine injuries, harmful reactions

(Natural News) Investigative journalist Sharyl Attkisson is logging all known cases of Wuhan coronavirus (Covid-19) “vaccine” injury and death in a running list on her website. Some of the latest updates include instances of CNS demyelination, functional neurological disorder, waning immunity, Bell’s palsy, antibody dependent enhancement (ADE), heart disorders, Guillain-Barre autoimmune paralysis, Graves’ disease and...
Source: NaturalNews.com - Category: Consumer Health News Source Type: news

Related Links:

We described a patient who developed four limb distal paraesthesia, postural instability, and facial  diplegia, ten days after vaccination with ChAdOx1 nCoV-19 (ABW1277). The electrophysiological findings were compatible with acute demyelinating motor polyneuropathy (Guillain-Barrè syndrome).DiscussionWe therefore want to describe a temporal correlation between administration of ChAdOx1 nCoV-19  (ABW1277) vaccine and GBS without evidence of other predisposing infectious or autoimmune factors. This paper aims to highlight the importance of pharmacovigilance and subsequent reports will be needed&nb...
Source: Neurological Sciences - Category: Neurology Source Type: research
We read with interest the letters “Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) Vaccine: Causality or casualty?” by Bril et al.1 and “Autoimmune hepatitis following sars-cov-2 VACCINE: MAY not be a casualty” by Rocco et al2 which highlight the hypothesis that COVID-19 mRNA-based vaccines might in crease the risk of developing autoimmune diseases. There are growing reports of autoimmune diseases developing after Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, including Guillain-Barré syndrome and Primary Biliary Cholangitis3.
Source: Journal of Hepatology - Category: Gastroenterology Authors: Tags: Letter to the Editor Source Type: research
AbstractGuillain –Barré syndrome (GBS) is an autoimmune disorder of the peripheral nervous system that typically develops within 4 weeks after infection. In addition to conventional infectious diseases with which we are familiar, emerging infectious diseases, such as Zika virus infection and coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have also been suggested to be associated with GBS. GBS is mainly categorized into a demyelinating subtype known as acute inflammatory demyelinating polyneuropathy (AIDP) and an axonal subtype known as acute mot...
Source: Neurology and Therapy - Category: Neurology Source Type: research
Conclusion: Our systematic review indicated the potential of the COVID-19 virus to trigger a myriad of autoimmune and rheumatic manifestations, which should be considered amid global efforts to combat COVID-19.
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
We present a review of the association between COVID-19 and autoimmune diseases, focusing on similarities in immune responses, cross-reactivity of SARS-CoV-2, the development of autoimmune diseases in COVID-19 patients and the risk of COVID-19 infection in patients with preexisting autoimmune conditions.
Source: Current Opinion in Rheumatology - Category: Rheumatology Tags: IMMUNOPATHOGENESIS AND TREATMENT OF AUTOIMMUNE DISEASES: Edited by George C. Tsokos Source Type: research
Authors: Akhter N, Ahmad S, Alzahrani FA, Dar SA, Wahid M, Haque S, Bhatia K, Sr Almalki S, Alharbi RA, Sindi AAA Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) uses Angiotensin- converting enzyme 2 (ACE2) receptors to infect host cells which may lead to coronavirus disease (COVID-19). Given the presence of ACE2 receptors in the brain and the critical role of the renin-angiotensin system (RAS) in brain functions, special attention to brain microcirculation and neuronal inflammation is warranted during COVID-19 treatment. Neurological complications reported among COVID-19 patients range from mi...
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
We describe a rare case of post-infective Acute Motor Axonal Neuropathy (AMAN) variant of Guillain-Barr è Syndrome (GBS) associated with myelitis and anti-GD1b positivity after SARS-CoV-2 infection. The patient referred to the hospital reporting a history of ten days lasting moderate fever, myalgia and anosmia, with the onset of progressive quadriparesis and ascending paraesthesias in the four limbs since five days from defervescence. A chest computed tomography demonstrated interstitial pneumonia with “ground glass opacities”, suggesting Coronavirus disease (COVID-19). The patient exhibited three negati...
Source: Journal of Neurology - Category: Neurology Source Type: research
SARS-CoV-2 and Guillain-Barré syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism. Cell Stress Chaperones. 2020 Jul 29;: Authors: Lucchese G, Flöel A Abstract Severe acute respiratory syndrome-related coronavirus 2 infection has been associated with Guillain-Barré syndrome. We investigated here the potential mechanism underlying the virus-induced damage of the peripheral nervous systems by searching the viral amino acid sequence for peptides common to human autoantigens associated with immune-mediated polyneuropathies. Our results show molecu...
Source: Cell Stress and Chaperones - Category: Cytology Authors: Tags: Cell Stress Chaperones Source Type: research
At the end of 2019, a novel pneumonia syndrome was identified in Wuhan, a city in the Hubei Province of China [1]. In February 2020, the World Health Organization designated the disease Covid-19, which stands for coronavirus disease 2019 [2]. While the majority of patients have mild symptoms without pneumonia or mild pneumonia, the clinical spectrum of symptomatic Covid-19 cases ranges from mild to critically ill [3]. As previously reported, patients with Covid-19 may show a range of immune complications, such as autoimmune hemolytic anemia (OIHA), immune thrombocytopenia (ITP), Guillain-Barr é and antiphospholipid ...
Source: Thrombosis Research - Category: Hematology Authors: Tags: Letter to the Editors-in-Chief Source Type: research
C, Anaya JM Abstract Coronavirus disease 2019 (COVID-19) has been categorized as evolving in overlapping phases. First, there is a viral phase that may well be asymptomatic or mild in the majority, perhaps 80% of patients. The pathophysiological mechanisms resulting in minimal disease in this initial phase are not well known. In the remaining 20% of cases, the disease may become severe and/or critical. In most patients of this latter group, there is a phase characterized by the hyperresponsiveness of the immune system. A third phase corresponds to a state of hypercoagulability. Finally, in the fourth stage organ i...
Source: Journal of Autoimmunity - Category: Allergy & Immunology Authors: Tags: J Autoimmun Source Type: research
More News: Autoimmune Disease | Brain | Cardiology | Coronavirus | COVID-19 | Guillain-Barr Syndrome | Health | Heart | Neurology | Vaccines | Websites